Tissue 3D printing
We are working on tissue 3D printing based on a combination of our devices with existing portable 3D bioprinting device, and proprietary scaffold hydrogels which will provide unique opportunity for development of breakthrough therapies for unmet medical needs. The platform and the method of embedment of the cellular product into injectable and printable biologic product are protected by broad portfolio of issued patents, pending patents and PCTs.

Therapy Development through partnerships
Using our devices as a platform, we are developing therapies with biotech/government partners for different clinical indications as below;

Fibralign’s BioBridge collagen matrix scaffold in combination with adipose stem cells derived from Mini-Stem System™ for treatment of lymphedema, vascular diseases.

Procore Bio’s hydrogel scaffold in combination with adipose stem cells derived from Mini-Stem System™ for orthopedic applications.
NIH sponsored small business grant (SBIR) for development of effective autologous point-of-care (POC) cell therapy for osteoarthritis.
Wound healing herapy applications using 3D printed biomaterials.

Model SVF -Stromal Vascular Fraction Cellular Product